Cure4Cancer

Cure4Cancer aims to accelerate cures for cancer as through multi-stakeholder, multi-regional collaboration.

[Cure4Cancer @Cure4C]

On this #WorldCancerDay, we are focused on equity and access. Cure4Cancer is working to improve patient outcomes nationwide by bringing together multi-regional stakeholders to accelerate the development of cancer cures.
https://t.co/UFVftaWxKy

[Cure4Cancer @Cure4C]

On this #WorldCancerDay, watch Senior Fellow in Global Public Health Bob Li discuss how investment in public health can advance China’s common prosperity agenda and move the world closer to the #Cure4Cancer.
https://t.co/EyST6aytIg

[Asia Society Policy Institute (ASPI) @AsiaPolicy]

On #WorldCancerDay, we look at the political and regulatory challenges to U.S.-China collaboration and how to expedite the harmonization of cancer clinical trials in a new paper by @patbeyrer. Read below👇 https://t.co/q6jk8u2yHc

[Cure4Cancer @Cure4C]

Dr. Bob Li reflects on how the U.S. and China can work together to accelerate the development of cancer cures. On #WorldCancerDay, we are committed to international cooperation in the fight against cancer:

https://t.co/xQD07hoylQ

[Patrick Beyrer @patbeyrer]

Pleased to publish a new @AsiaSociety report on #WorldCancerDay.

Drawing on the work of scientists, policymakers, and more, this report identifies the challenges and opportunities within US-China scientific ties to change cancer care as we know it. 🧵
https://t.co/EWtf8VyVvG

[Cure4Cancer @Cure4C]

On #WorldCancerDay, we are committed to driving progress to decrease the cancer burden worldwide by raising public awareness on the benefits of international collaboration to accelerate the development of cancer cures.
Learn more:
https://t.co/WCCuvbVzMt

[Asia Society Policy Institute (ASPI) @AsiaPolicy]

#Cancer claims 10 million lives annually, straining families & #healthcare systems worldwide.

Our latest report in the Advancing Global Health Equity for the #Cure4Cancer series with @Cure4C examines how international collaboration and regulatory harmonization in clinical trials—through the lens of the U.S.-#Australia partnership—can make a difference.

Read the full report here: https://t.co/YphkqqTRj8

[Cure4Cancer @Cure4C]

Cancer claims 10M lives annually, straining families & #healthcare systems worldwide. The latest report in the Advancing Global Health Equity for the #Cure4Cancer series by @asiapolicy and @Cure4C examines how international collaboration and regulatory harmonization in clinical trials—through the lens of the U.S.-Australia partnership—can make a difference. Read more in the full report here: https://t.co/K62UrfRX33

[Asia Society Policy Institute (ASPI) @AsiaPolicy]

Could the Chinese biotech sector be the next risky frontier between the United States and China? Read this new and timely ASPI and @Cure4C paper by @patbeyrer on U.S.-China biotech competition. https://t.co/9kMfSKJW0K

[Cure4Cancer @Cure4C]

Watch our full interview with Dr. Daly: https://t.co/dXeqZ7a2fY

[Cure4Cancer @Cure4C]

Clinical trial remote monitoring and data collection could improve participation by removing financial and logistic burdens. @BobbyDalyMD
& Dr. Bob Li published a study in
@JAMANetworkOpen that evaluated remote technologies and identified areas for growth. @BBGNewEconomy #InternationalCancerCoalition

[Cure4Cancer @Cure4C]

Read the paper: https://t.co/wj49axhQBq

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

Clinical trial remote monitoring and data collection could improve participation by removing financial and logistic burdens. @BobbyDalyMD & Dr. Bob Li published a study in @JAMANetworkOpen that evaluated remote technologies and identified areas for growth. https://t.co/A5D2nqxqiI

[Cure4Cancer @Cure4C]

On #WorldCancerDay, we are committed to a #GlobalCancerMoonshot, driving progress to decrease the cancer burden worldwide by raising public awareness to accelerate the development of cancer cures. @AsiaPolicy
Learn more: https://t.co/WCCuvbV1WV

[Cure4Cancer @Cure4C]

Focusing on equity and access, Cure4Cancer is working to improve outcomes for patients nationwide by bringing together multi-regional stakeholders to accelerate the development of cancer cures. #GlobalCancerMoonshot #WorldCancerDay @AsiaPolicy

https://t.co/ToAmB8ClCt

[Cure4Cancer @Cure4C]

Join the movement and visit us [6/6]: https://t.co/WCCuvbV1WV

[Cure4Cancer @Cure4C]

Ahead of #WorldCancerDay, we are delighted to highlight our commitment to a #GlobalCancerMoonshot. Our Cure4Cancer conference highlighted the importance of advancing global health equity and harmonization. [1/6] https://t.co/uTulH3QzVf

[Cure4Cancer @Cure4C]

@US_FDA Dr. Richard Pazdur joined us for an interview on the need to focus on multi-regional clinical trials as the critical path to lessen the cancer burden worldwide. [5/6]
https://t.co/mfp0kTilhY